Grand Rounds: Mycoplasma Pneumoniae - What's all the hype about!
05-16-2025
By Shankar Upadhyayula, MD , Director, Pediatric Infectious Disease, Akron Children's, Akron, OH
Objectives (Educational Content) :
1. Explain the unique characteristics of Mycoplasma pneumoniae and highlight the seasonal trends and demographic factors influencing infection rates. 2. Analyze and discuss potential reasons for the increase in Mycoplasma pneumoniae infections following the COVID-19 pandemic 3. Identify the difficulties in diagnosing Mycoplasma pneumoniae due to its unique biological characteristics and outline the standard treatment protocols.
Target Audience:
General pediatricians, family physicians, nurse practitioners, physician assistants, social workers, psychologists, and nurses.
Identified Gap:
Despite growing awareness of Mycoplasma pneumoniae, significant gaps remain in understanding its unique characteristics, the factors influencing infection rates, and the challenges in diagnosis and treatment. These gaps are particularly evident in seasonal trends, demographic factors, noticeable increases in infections following the COVID-19 pandemic and increasing resistance to standard treatment protocols.
Estimated Time to Complete the Educational Activity:
1 hour(s)
Expiration Date for CE/CME Credit:
05-15-2026
Method of Participation in the Learning Process:
The learner will view the presentation, successfully complete a post-test and complete an activity evaluation.
Evaluation Methods:
All learners must successfully complete a post-test, as well as an activity evaluation, to claim CE/CME credit.
Disclosure:
The following presenter has indicated there are no financial relationships with any ineligible companies: Shankar Upadhyayula, MD. The following planning committee member has indicated that a financial relationship with an ineligible company: All relationships have been mitigated. The remaining planning committee/CME committee members have indicated that they have no financial relationships with any ineligible companies.
Accreditation Statement:
Akron Children’s Hospital is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.
Akron Children’s Hospital designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Bibliography:
1. Waites KB, Ratliff A, Crabb DM, Xiao L, Qin X, Selvarangan R, Tang YW, Zheng X, Dien Bard J, Hong T, Prichard M, Brooks E, Dallas S, Duffy L, Mixon E, Fowler KB, Atkinson TP. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program. J Clin Microbiol. 2019 Oct 23;57(11):e00968-19. doi: 10.1128/JCM.00968-19. PMID: 31484701; PMCID: PMC6813023.
2. Chen YC, Hsu WY, Chang TH. Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia. Emerg Infect Dis. 2020 Jul;26(7):1382-1391. doi: 10.3201/eid2607.200017. PMID: 32568052; PMCID: PMC7323531.
3. Lanata MM, Wang H, Everhart K, Moore-Clingenpeel M, Ramilo O, Leber A. Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA. Emerg Infect Dis. 2021 Jun;27(6):1588-1597. doi: 10.3201/eid2706.203206. PMID: 34013867; PMCID: PMC8153876.
